Initial Clinical Response Predicts Outcome and Is Associated With Dose Schedule in Metastatic Melanoma and Renal Cell Carcinoma Patients Treated With High-Dose Interleukin 2

被引：0

作者：

Kathryn Spanknebel

Kenneth Y. Cheung

John Stoutenburg

Karl Hurst-Wicker

Charles Hesdorffer

Gail DeRaffele RN

and Howard L. Kaufman

机构：

[1] Columbia University College of Physicians and Surgeons,Department of Surgery

[2] Columbia University Mailman School of Public Health,Department of Biostatistics

[3] Columbia University College of Physicians and Surgeons,Department of Medicine, Division of Hematology and Oncology

来源：

Annals of Surgical Oncology | 2005年 / 12卷

关键词：

Melanoma; Renal cell carcinoma; Immunotherapy; Interleukin 2; Metastatic.;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：381 / 390

页数：9

共 114 条

[41]

Dillman RO(undefined)undefined undefined undefined undefined-undefined

[42]

O’Connor AA(undefined)undefined undefined undefined undefined-undefined

[43]

Simpson L(undefined)undefined undefined undefined undefined-undefined

[44]

Barth NM(undefined)undefined undefined undefined undefined-undefined

[45]

VanderMolen LA(undefined)undefined undefined undefined undefined-undefined

[46]

Vanderplas P(undefined)undefined undefined undefined undefined-undefined

[47]

Quan WD(undefined)undefined undefined undefined undefined-undefined

[48]

Quan FM(undefined)undefined undefined undefined undefined-undefined

[49]

McDermott D(undefined)undefined undefined undefined undefined-undefined

[50]

Flaherty L(undefined)undefined undefined undefined undefined-undefined